Premier Anti-Aging Co., Ltd. (TYO:4934)
580.00
-9.00 (-1.53%)
Jun 19, 2026, 3:30 PM JST
Premier Anti-Aging Balance Sheet
Financials in millions JPY. Fiscal year is August - July.
Millions JPY. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Cash & Equivalents | 4,841 | 4,655 | 4,760 | 4,670 | 2,973 | 6,061 |
Cash & Short-Term Investments | 4,841 | 4,655 | 4,760 | 4,670 | 2,973 | 6,061 |
Cash Growth | 5.68% | -2.21% | 1.93% | 57.08% | -50.95% | - |
Receivables | 1,188 | 1,421 | 1,727 | 2,080 | 3,071 | 3,399 |
Inventory | 1,794 | 1,459 | 1,586 | 1,909 | 4,361 | 2,699 |
Prepaid Expenses | - | 214 | 251 | 306 | 418 | 183 |
Other Current Assets | 588 | 324 | 558 | 264 | 693 | 137 |
Total Current Assets | 8,411 | 8,073 | 8,882 | 9,229 | 11,516 | 12,479 |
Property, Plant & Equipment | 570 | 553 | 610 | 77 | 110 | 120 |
Long-Term Investments | - | 518 | 510 | 799 | 327 | 193 |
Goodwill | 278 | 310 | 352 | 394 | - | - |
Other Intangible Assets | 611 | 604 | 647 | 1,117 | 266 | 149 |
Long-Term Deferred Tax Assets | - | 81 | - | 517 | 80 | 128 |
Other Long-Term Assets | 604 | 1 | 1 | 2 | 1 | 2 |
Total Assets | 10,474 | 10,140 | 11,002 | 12,135 | 12,300 | 13,071 |
Accounts Payable | 330 | 203 | 204 | 258 | 435 | 810 |
Accrued Expenses | 40 | 78 | 81 | 53 | 18 | 53 |
Short-Term Debt | 668 | 405 | 1,008 | 568 | 390 | - |
Current Portion of Long-Term Debt | 178 | 234 | 411 | 256 | 322 | 365 |
Current Income Taxes Payable | 323 | 995 | 894 | 1,358 | 1,734 | 4,211 |
Other Current Liabilities | 1,370 | 1,082 | 1,161 | 523 | 321 | 152 |
Total Current Liabilities | 2,909 | 2,997 | 3,759 | 3,016 | 3,220 | 5,591 |
Long-Term Debt | 395 | 468 | 1,023 | 1,436 | 701 | 545 |
Long-Term Deferred Tax Liabilities | - | 50 | 34 | 34 | - | - |
Other Long-Term Liabilities | 34 | 16 | 63 | 40 | 31 | 32 |
Total Liabilities | 3,338 | 3,531 | 4,879 | 4,526 | 3,952 | 6,168 |
Common Stock | 50 | 1,351 | 1,351 | 1,351 | 1,351 | 1,348 |
Additional Paid-In Capital | 2,653 | 1,351 | 1,351 | 1,351 | 1,351 | 1,348 |
Retained Earnings | 4,419 | 3,876 | 3,404 | 4,888 | 5,622 | 4,213 |
Treasury Stock | -1 | -1 | -1 | -1 | -1 | -1 |
Comprehensive Income & Other | 15 | 32 | 18 | 20 | 25 | -5 |
Shareholders' Equity | 7,136 | 6,609 | 6,123 | 7,609 | 8,348 | 6,903 |
Total Liabilities & Equity | 10,474 | 10,140 | 11,002 | 12,135 | 12,300 | 13,071 |
Total Debt | 1,241 | 1,107 | 2,442 | 2,260 | 1,413 | 910 |
Net Cash (Debt) | 3,600 | 3,548 | 2,318 | 2,410 | 1,560 | 5,151 |
Net Cash Growth | 5.29% | 53.06% | -3.82% | 54.49% | -69.72% | - |
Net Cash Per Share | 412.30 | 406.34 | 265.81 | 276.36 | 178.63 | 601.79 |
Filing Date Shares Outstanding | 8.72 | 8.72 | 8.72 | 8.72 | 8.72 | 8.72 |
Total Common Shares Outstanding | 8.72 | 8.72 | 8.72 | 8.72 | 8.72 | 8.72 |
Working Capital | 5,502 | 5,076 | 5,123 | 6,213 | 8,296 | 6,888 |
Book Value Per Share | 818.31 | 757.88 | 702.15 | 872.55 | 957.30 | 791.64 |
Tangible Book Value | 6,247 | 5,695 | 5,124 | 6,098 | 8,082 | 6,754 |
Tangible Book Value Per Share | 716.37 | 653.07 | 587.59 | 699.28 | 926.79 | 774.55 |